To exclude the change in proliferation rate because of changes to C/EBPβ protein levels, a cisplatin-induced tumor reduction rate was calculated based on the tumor volume in a phosphate-buffered saline (PBS)-treated group at each time point. Here, CEBPB is linked to neoplasm.